Assessment of Immune Status in Dynamics for Patients with Cancer Undergoing Immunotherapy

Immunotherapy using immune checkpoint inhibitors has revolutionized the treatment, and many types of cancer show a response rate of 20–40% and a significant increase in five-year survival. However, immunotherapy is expensive and may cause serious adverse events. Therefore, a predictive method allowi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xenia Elena, Bacinschi, Nicoleta Gales, Laurentia, Florina Zgura, Anca, Iliescu, Laura, Maricela Anghel, Rodica, Haineala, Bogdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112935/
https://www.ncbi.nlm.nih.gov/pubmed/34054956
http://dx.doi.org/10.1155/2021/6698969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112935/
https://www.ncbi.nlm.nih.gov/pubmed/34054956
http://dx.doi.org/10.1155/2021/6698969

Ejemplares similares